News
Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.
2d
Zacks Investment Research on MSNEli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?Eli Lilly and Company’s LLY shares have lost 8.2% in the past month. A lot of this price decline is due to the global ...
The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results